| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Go Red for Women |
From the Division of Cardiovascular Medicine, The Gill Heart Institute, University of Kentucky, VA Medical Center, Lexington.
Correspondence to Susan S. Smyth, 326 Charles T Wethington Building, 900 S Limestone, Lexington, KY 40536-0200. E-mail SusanSmyth{at}uky.edu
Sex-based differences in the prevalence and presentation of arterial and venous thrombosis exist, and emerging data indicate that men and women do not accrue equal benefit from antithrombotic therapy. Sex hormones alter procoagulant protein expression and the function of blood and vascular cells. Sex-based differences in platelet function have been reported, and in animal models, sex-based differences in thrombosis have been noted. Here we review plausible mechanisms that may explain how sex functions as a modifier of thrombosis and summarize clinical data on the interaction between sex and response to antithrombotic therapy.
Key Words: anti-thrombotic therapy female platelet thrombosis
Related Article:
Arterioscler Thromb Vasc Biol 2009 29: 277-278.
This article has been cited by other articles:
![]() |
D. P. Faxon Women Are Like Men ... Sometimes J. Am. Coll. Cardiol., November 17, 2009; 54(21): 1946 - 1948. [Full Text] [PDF] |
||||
![]() |
N. Mackman and S. Smyth Cardiovascular Disease in Women Arterioscler Thromb Vasc Biol, March 1, 2009; 29(3): 277 - 278. [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2009 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |